Recombinant Human APOA4 Protein(Sumo Tag)

SKU: PDEH100609

Size:100μg

Storage:Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping:This product is provided as lyophilized powder which is shipped with ice packs.

Exp date:12 months

Category ID_II:Recombinant Proteins

Category ID_III:Others

Abbreviation:APOA4

Target Synonym:Apolipoprotein A;APOA4;Apo AIV;APOA 4;ApoA IV;ApoAIV;ApoA-IV;Apo-AIV;Apolipoprotein A IV;Apolipoprotein A4;Apolipoprotein A-IV;MGC142154;MGC142156;APOA4;Apolipoprotein A-IV;ApoA-IV;ApoAIV;apoA4;

Research Areas:Signal Transduction;Cardiovascular;Cancer;Metabolism

Conjugation:

Target Species:Human

Expression Host:E.coli

Application:

Fusion tag:N-Sumo

UNIProt ID:P06727

Accession:P06727

Background:Apolipoprotein is genetically associated with the risk of Alzheimer's disease (AD). The APOA1, APOC3, and APOA4 genes are closely linked and located on human chromosome 11. There was a decreased trend for levels of APOA1, APOC3, and APOA4 in AD patients. CONCLUSION: Low levels of APOA1, APOC3, and APOA4 are associated with risk of AD. APOA1, APOC3, and APOA4 should be developed as combined drμgs for the therapy of AD. SNP(single nucleotide polymorphisms)in APOA1and APOA4 genes influences atherogenic characteristics of LDL particles in response to diet.

Concentration:

Activity:Not validated for activity

Sequence:Ser23-Ser396

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation:Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution:It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin:< 10 EU/mg of the protein as determined by the LAL method.

Calculated MW:54 kDa

ObservedMW:60 kDa